Psoriasis associated with inflammatory bowel disease: a cross‐sectional analysis in the NIH All of Us Research Program

International Journal of DermatologyVolume 63, Issue 3 p. e82-e83 Clinical Correspondence Psoriasis associated with inflammatory bowel disease: a cross-sectional analysis in the NIH All of Us Research Program Marina Z. Joel BS, Marina Z. Joel BS orcid.org/0000-0001-8208-011X Johns Hopkins University School of Medicine, Baltimore, MD, USA These authors contributed equally as co-first authors.Search for more papers by this authorAnthony M. Wride BA, Anthony M. Wride BA orcid.org/0000-0002-1804-885X Yale School of Medicine, New Haven, CT, USA These authors contributed equally as co-first authors.Search for more papers by this authorJeffrey M. Cohen MD, Corresponding Author Jeffrey M. Cohen MD [email protected] orcid.org/0000-0002-7709-0548 Department of Dermatology, Yale School of Medicine, New Haven, CT, USA Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT, USASearch for more papers by this author Marina Z. Joel BS, Marina Z. Joel BS orcid.org/0000-0001-8208-011X Johns Hopkins University School of Medicine, Baltimore, MD, USA These authors contributed equally as co-first authors.Search for more papers by this authorAnthony M. Wride BA, Anthony M. Wride BA orcid.org/0000-0002-1804-885X Yale School of Medicine, New Haven, CT, USA These authors contributed equally as co-first authors.Search for more papers by this authorJeffrey M. Cohen MD, Corresponding Author Jeffrey M. Cohen MD [email protected] orcid.org/0000-0002-7709-0548 Department of Dermatology, Yale School of Medicine, New Haven, CT, USA Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT, USASearch for more papers by this author First published: 10 January 2024 https://doi.org/10.1111/ijd.17015 Conflicts of interest: JMC serves on a data and safety monitoring board for Advarra and has served as a consultant for Novartis. The remaining authors have no conflicts of interest to declare. Funding source: MZJ is funded by the Kelly Gene Cook Sr. Foundation. AMW was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number T35DK104689. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. IRB information: This study has been deemed not to be human subjects research by the Yale University Institutional Review Board. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Pietrzak D, Pietrzak A, Krasowska D, Borzęcki A, Franciszkiewicz-Pietrzak K, Polkowska-Pruszyńska B, et al. Digestive system in psoriasis: an update. Arch Dermatol Res. 2017; 309(9): 679–693. 10.1007/s00403-017-1775-7 CASPubMedWeb of Science®Google Scholar 2Fu Y, Lee CH, Chi CC. Association of psoriasis with inflammatory bowel disease: a systematic review and meta-analysis. JAMA Dermatol. 2018; 154(12): 1417–1423. 10.1001/jamadermatol.2018.3631 PubMedWeb of Science®Google Scholar 3Halling ML, Kjeldsen J, Knudsen T, Nielsen J, Hansen LK. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol. 2017; 23(33): 6137–6146. 10.3748/wjg.v23.i33.6137 PubMedWeb of Science®Google Scholar 4Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007; 80(2): 273–290. 10.1086/511051 CASPubMedWeb of Science®Google Scholar 5Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314(5804): 1461–1463. 10.1126/science.1135245 CASPubMedWeb of Science®Google Scholar Volume63, Issue3March 2024Pages e82-e83 ReferencesRelatedInformation